Cantini G, Trabucco M, Di Franco A, Mannucci E, Luconi M
As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes
Psychiatry 18 (9), 961962
Lactate acts on the lactate receptor, G-protein-coupled receptor 81 (GPR81) and augments the proliferative potential of intestinal stem cells [119,144]
Sci Rep 14 , 24433 (2024)
Comprehensive Progress Tracking: The program offers tools to monitor your progress towards your goals, including dietary intake, exercise, weight changes, and other health metrics, helping you stay informed about your journey
